Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism
Pengyun Li, Qiaohong Lin, Shiyang Sun, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 9
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Stearoyl coenzyme A desaturase-1: multitasker in cancer, metabolism, and ferroptosis
Utsav Sen, Charles Coleman, Triparna Sen
Trends in cancer (2023) Vol. 9, Iss. 6, pp. 480-489
Open Access | Times Cited: 95
HSPB1 facilitates chemoresistance through inhibiting ferroptotic cancer cell death and regulating NF-κB signaling pathway in breast cancer
Yiran Liang, Yajie Wang, Yan Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 7
Open Access | Times Cited: 43
Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors
Yi-Ming Bo, Xin Zhao, Liliang Li
Clinical Science (2024) Vol. 138, Iss. 6, pp. 413-434
Closed Access | Times Cited: 22
Metabolism-regulated ferroptosis in cancer progression and therapy
Lvlan Ye, Xiangqiong Wen, Jiale Qin, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 20
Regulation of ferroptosis by PI3K/Akt signaling pathway: a promising therapeutic axis in cancer
Hua Su, Chao Peng, Yang Liu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19
Ferroptosis: the emerging player in remodeling triple-negative breast cancer
Jie Li, Dejiao He, Sicheng Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Mechanism of ferroptosis in a rat model of premature ovarian insufficiency induced by cisplatin
Rong Du, Xi Cheng, Jingjing Ji, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 25
Multiple forms of cell death: A focus on the PI3K/AKT pathway
Jiawei Xu, Yu Li, Meili Kang, et al.
Journal of Cellular Physiology (2023) Vol. 238, Iss. 9, pp. 2026-2038
Closed Access | Times Cited: 25
Ferroptosis as a promising targeted therapy for triple negative breast cancer
Kasra Mokhtarpour, Sepideh Razi, Nima Rezaei
Breast Cancer Research and Treatment (2024) Vol. 207, Iss. 3, pp. 497-513
Closed Access | Times Cited: 7
Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills
Valeria Consoli, Antonino N. Fallica, Valeria Sorrenti, et al.
Antioxidants and Redox Signaling (2023) Vol. 40, Iss. 1-3, pp. 40-85
Open Access | Times Cited: 14
Ferroptosis induction via targeting metabolic alterations in triple-negative breast cancer
Yaru Wang, Yue Sun, Feiran Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 169, pp. 115866-115866
Open Access | Times Cited: 14
Novel nanoparticle CS-C60-Fe3O4 magnetically induces tissue-specific aggregation and enhances thermal ablation of hepatocellular carcinoma
Jie Sun, Zhengyao Chang, Xudong Gao, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Advancing immunotherapy in triple negative breast Cancer: A novel multimodal theranostic nanoplatform integrating synergetic ferroptosis and photothermal therapy
Long Cheng, Yi‐Bo Qiu, Ling‐Yun He, et al.
Chemical Engineering Journal (2024) Vol. 485, pp. 150057-150057
Closed Access | Times Cited: 4
Dietary Methionine Restriction Alleviates Cognitive Impairment in Alzheimer’s Disease Mice via Sex-Dependent Modulation on Gut Microbiota and Tryptophan Metabolism: A Multiomics Analysis
Yuyu Zhang, Tianqi Liu, Fei Pan, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
Metabolic Reprogramming and Adaption in Breast Cancer Progression and Metastasis
Qianying Zuo, Yibin Kang
Advances in experimental medicine and biology (2025), pp. 347-370
Closed Access
Treating incurable non-communicable diseases by targeting iron metabolism and ferroptosis
Ruoxuan Ni, Jianwei Jiang, Fudi Wang, et al.
Science China Life Sciences (2025)
Closed Access
Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment
Mengting Wan, Shuaikang Pan, Benjie Shan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation
Ling Lin, Zaixiang Fang, Guohao Liu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Monounsaturated fatty acids promote cancer radioresistance by inhibiting ferroptosis through ACSL3
Yulin Cao, Jiuming Li, Runsheng Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Recent advances of ferroptosis in tumor: From biological function to clinical application
Shunfeng Hu, Yurou Chu, Xiangxiang Zhou, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115419-115419
Open Access | Times Cited: 11
Phytocannabinoids CBD, CBG, and their Derivatives CBD-HQ and CBG-A Induced In Vitro Cytotoxicity in 2D and 3D Colon Cancer Cell Models
Dorota Bęben, Oliwia Siwiela, Anna Szyjka, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 4, pp. 3626-3639
Open Access | Times Cited: 3
Cannabis and cancer: unveiling the potential of a green ally in breast, colorectal, and prostate cancer
Husam ALSalamat, Sara Feras Abuarab, Hazem Mohamed Salamah, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 3
Cannabinoids and triple-negative breast cancer treatment
Luka Dobovišek, Simona Borštnar, Nataša Debeljak, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Research Progress on Ferroptosis and Nanotechnology-Based Treatment in Triple-Negative Breast Cancer
Jun Zhang, Shengjun Zhang, Minli Liu, et al.
Breast Cancer Targets and Therapy (2024) Vol. Volume 16, pp. 347-358
Open Access | Times Cited: 2
Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential
Chuchu Xu, Yi‐An Chen, Qinghong Yu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top